The two FDA-approved drugs have demonstrated in clinical trials the capability to slow cognitive decline by several months, The Washington Post reported Oct. 8.

An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...

Muscae volitantes — “eye floaters” are those little, transparent threads that you see floating across your eyeball. Generally ...

Dementia in Parkinson disease occurs less frequently or much later in the disease course than previously expected.

The brain has a waste-disposal system that clears away junk proteins that contribute to the development of dementia and ...

The brain has a waste-disposal system that clears away junk proteins that contribute to the development of dementia an ...

A soon-to-be-published study analyzed more than 6 million patient records to help support a growing link between heart and ...

Athens residents and Ohio University students came together to support those affected by Alzheimer’s, raising over $40,000.

Scientists have announced a significant breakthrough in the development of a drug to combat Alzheimer's disease. The drug, ...

This drug has the potential to be more targeted than others currently being studied, and we hope it will result in fewer ...

Frontotemporal dementia can be hard to diagnose because while dementia can be part of the illness, it's not a factor in all ...

Alzheimer’s disease is not a normal part of getting older. Scientists are working hard to find out why it happens and how to ...